— Quest Diagnostics (NYSE: DGX) reported third quarter 2019 adjusted EPS of $1.76 vs. $1.71 expected.
Check below Quest Diagnostics Q3 2019 earnings infograph
— GAAP EPS of continuing operations increased 2.8% year-over-year to $1.56.
— Revenue grew 3.5% to $1.96 billion vs. $1.94 billion expected.
— Diagnostic Information Services revenue grew 3.7% to $1.88 billion.
— For fiscal 2019, revenue is expected to be approximately $7.72 billion.
— FY19 adjusted EPS is pegged to be between $6.45 and $6.50. Reported EPS from continuing operations is touted to be $5.48-5.43.
— DGX stock, which reached its 52-week high on Sept. 20, inched down 0.37% to $102.28 yesterday.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
